OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
127
Results
Show all
Save search
Copy query
Show results for
Unknown
(126)
Genomic
(1)
Repository
dbGaP
(1)
Publication Date
Release Date
2022
(20)
2021
(13)
2025
(12)
2024
(12)
2023
(11)
2020
(11)
2015
(7)
2018
(6)
2017
(6)
2014
(6)
2019
(5)
2013
(5)
2012
(5)
2016
(4)
2010
(2)
2026
(1)
Previous
page
1 / 13
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
13
Next
page
Sort
by:
Relevance
Page size
10
A consensus layer V pyramidal neuron can sustain interpulse-interval coding.
Not available
S-EPMC5509228
|
biostudies-literature
Cite
Genome-wide association study of primary dentition pit-and-fissure and smooth surface caries.
Not available
S-EPMC4043868
|
biostudies-literature
Cite
Chronic stress and antidepressant treatment alter purine metabolism and beta oxidation within mouse brain and serum.
Not available
S-EPMC7582177
|
biostudies-literature
Cite
Early outcomes of robotic vs open living donor right hepatectomy in a US Center.
Not available
S-EPMC11870880
|
biostudies-literature
Cite
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.
Not available
S-EPMC5089161
|
biostudies-literature
Cite
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis.
Not available
S-EPMC10543534
|
biostudies-literature
Cite
3q27.1 microdeletion causes prenatal and postnatal growth restriction and neurodevelopmental abnormalities.
Not available
S-EPMC8895857
|
biostudies-literature
Cite
Maternal Bacterial Engraftment in Multiple Body Sites of Cesarean Section Born Neonates after Vaginal Seeding-a Randomized Controlled Trial.
Not available
S-EPMC10294643
|
biostudies-literature
Cite
Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study.
Not available
S-EPMC11346858
|
biostudies-literature
Cite
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis.
Not available
S-EPMC11227354
|
biostudies-literature
Cite
Previous
page
1 / 13
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
13
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets